2024 August 1 Release
Last updated
Last updated
phs001661 (GPCD-A): NHLBI TOPMed: Genetic Causes of Complex Pediatric Disorders - Asthma (GCPD-A)
phs001732 (CARE_TREXA): NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma (TREXA)
phs001782 (CARE_BADGER): NHLBI TOPMed: Best ADd-on Therapy Giving Effective Response (BADGER)
phs001729 (CARE_CLIC): NHLBI TOPMed: Characterizing the Response to a Leukotriene Receptor Antagonist and an Inhaled Corticosteroid (CLIC)
phs001727 (PIMA): NHLBI TOPMed: Pathways to Immunologically Mediated Asthma (PIMA)
phs001544 (MPP): NHLBI TOPMed - NHGRI CCDG: Malmo Preventive Project (MPP)
phs001598 (JHU_AF): NHLBI TOPMed - NHGRI CCDG: The Johns Hopkins University School of Medicine Atrial Fibrillation Genetics Study
phs001040 (WGHS): NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women
phs001624 (BioVU_AF): NHLBI TOPMed - NHGRI CCDG: The Vanderbilt University BioVU Atrial Fibrillation Genetics Study
phs001024 (Partners): NHLBI TOPMed: Partners HealthCare Biobank
phs003637 (BioLINCC_SHHS): Sleep Heart Health Study (SHHS-BioLINCC)
phs003621 (BioLINCC_GUIDE-IT): Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT-BioLINCC)
phs003562 (ACCORD): Action to Control Cardiovascular Risk in Diabetes (ACCORD - Imaging)
phs001730 (CARE_PACT): NHLBI TOPMed: Pediatric Asthma Controller Trial (PACT)
phs001725 (GGAF): NHLBI TOPMed - NHGRI CCDG: Groningen Genetics of Atrial Fibrillation (GGAF) Study
phs001662 (LTRC): NHLBI TOPMed: Lung Tissue Research Consortium (LTRC)
phs001608 (OMG): NHLBI TOPMed: Outcome Modifying Genes in Sickle Cell Disease (OMG)
phs001466 (PharmHU): NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)
phs001514 (Walk_PHaSST_SCD): NHLBI TOPMed: Walk-PHaSST Sickle Cell Disease (SCD)
phs001682 (PUSH_SCD): NHLBI TOPMed: Pulmonary Hypertension and the Hypoxic Response in SCD (PUSH)
phs001726 (CAMP): NHLBI TOPMed: Childhood Asthma Management Program (CAMP)